新型类似于支架的装置用于治疗二次性至良性前列腺增生后的下泌尿道症状
Roseanne Ferreira1, Mario Henrique Bitar Siqueira2, Naeem Bhojani3
1Division of Urology, Western University, London, ON, Canada.
前列腺支架在良性前列腺增生症方面取得了重大进展,提供了更好的结果. 现代设计为管理下泌尿道症状提供了最少的侵入性选择.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 生物医学工程 生物医学工程
背景情况:
- 良性前列腺增生症 (BPH) 导致下泌尿道症状 (LUTS).
- 前列腺支架被开发用于管理由BPH引起的LUTS.
- 早期的前列腺支架设计存在诸如迁移和层等局限性.
研究的目的:
- 审查前列腺支架在管理LUTS的演变.
- 为了突出支架设计和材料的进步.
- 讨论前列腺支架的当前作用和未来方向.
主要方法:
- 关于前列腺支架开发的文献综述.
- 对历史和现代支架设计的分析.
- 对临床结果和并发症的评估.
主要成果:
- 显著改善了支架耐用性和生物相容性.
- 现代支架为LUTS提供了一种最小侵入性的替代方案.
- 通过当代的前列腺支架技术,改善了患者的治疗结果.
结论:
- 前列腺支架已经发展成为用于LUTS管理的有效设备.
- 目前正在进行的研究重点是优化患者选择和长期疗效.
- 未来的发展旨在减少程序负担并改善症状缓解.
更多相关视频
03:55Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis
Published on: October 18, 2024
05:19A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
相关概念视频
Urinary Tract Calculi III: Medical Management
Anatomy of the Genitourinary System II: Bladder and Urethra
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Urinary Tract Calculi VI: Surgical Management
Mitral Stenosis III: Medical Management
